Techno Medica Co., Ltd. (6678) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Eiken Chemical Co., Ltd.

Shofu, Inc.

Rion Co., Ltd.

FRANCE BED HOLDINGS CO., LTD.

Medikit Co., Ltd.

Techno Medica Co., Ltd.

Seed Co., Ltd. /7743/

CYBERDYNE, Inc.

Mizuho Medy Co., Ltd.

Japan Medical Dynamic Marketing, Inc.

ReproCELL, Inc.

Why is Techno Medica Co., Ltd. ?

Company has very low debt and has enough cash to service the debt requirements

Poor long term growth as Net Sales has grown by an annual rate of 0.19% and Operating profit at 0.67% over the last 5 years

The company has declared Negative results for the last 3 consecutive quarters

PRE-TAX PROFIT(Q) At JPY 13.49 MM has Fallen at -94.72%
NET PROFIT(Q) At JPY 9.46 MM has Fallen at -94.55%
ROCE(HY) Lowest at 6.17%

With ROE of 6.89%, it has a very attractive valuation with a 1.10 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 14.66%, its profits have fallen by -26.4%

Underperformed the market in the last 1 year

The stock has generated a return of 14.66% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 28.54%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Techno Medica Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Techno Medica Co., Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Techno Medica Co., Ltd.

14.66%

0.86

19.42%

Japan Nikkei 225

28.54%

1.11

25.75%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

0.19%

EBIT Growth (5y)

0.67%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.63

Sales to Capital Employed (avg)

0.70

Tax Ratio

23.88%

Dividend Payout Ratio

46.87%

Pledged Shares

Institutional Holding

ROCE (avg)

34.72%

ROE (avg)

7.90%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.10

EV to EBIT

5.24

EV to EBITDA

4.87

EV to Capital Employed

1.28

EV to Sales

0.69

PEG Ratio

Dividend Yield

ROCE (Latest)

24.41%

ROE (Latest)

6.89%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-23What is not working for the Company

PRE-TAX PROFIT(Q)

At JPY 13.49 MM has Fallen at -94.72%

NET PROFIT(Q)

At JPY 9.46 MM has Fallen at -94.55%

ROCE(HY)

Lowest at 6.17%

RAW MATERIAL COST(Y)

Grown by 8.63% (YoY

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.87%

NET SALES(Q)

Fallen at -12.1%

OPERATING PROFIT(Q)

Lowest at JPY 20.87 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 1.19 %

EPS(Q)

Lowest at JPY 2.38

Here's what is not working for Techno Medica Co., Ltd.

Pre-Tax Profit

At JPY 13.49 MM has Fallen at -94.72%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (JPY MM)

Net Profit

At JPY 9.46 MM has Fallen at -94.55%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (JPY MM)

Net Sales

Lowest at JPY 1,757.1 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (JPY MM)

Net Sales

Fallen at -12.1%

Year on Year (YoY)

MOJO Watch

Near term sales trend is negative

Net Sales (JPY MM)

Operating Profit

Lowest at JPY 20.87 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (JPY MM)

Operating Profit Margin

Lowest at 1.19 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at JPY 13.49 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (JPY MM)

Net Profit

Lowest at JPY 9.46 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (JPY MM)

EPS

Lowest at JPY 2.38

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (JPY)

Inventory Turnover Ratio

Lowest at 1.87%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Raw Material Cost

Grown by 8.63% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales